US hemp Roundtable: House Leaders Slam FDA Technical Assistance On Hemp Legislation

US hemp roundtable write…

Lead sponsors of H.R. 6134, the CBD Product Safety and Standardization Act, are calling on the U.S. Food and Drug Administration (FDA) to provide answers as to why the agency has failed to establish a regulatory framework for hemp-derived CBD.

A letter sent to FDA Commissioner, Dr. Robert Califf, from Reps. Kathleen Rice (D-NY), Morgan Griffith (R-VA), Angie Craig (D-ME), and Dan Crenshaw (R-TX) criticizes the FDA for a lack of thoughtful, applicable feedback provided within the technical assistance (TA) requested on behalf of H.R. 6134, calling it “a reformatting of a document provided to Congress over two years ago,” claiming that it, “does not address provisions of [the] bill drafted specifically to address product safety,” and, “a completely insufficient response at this moment when cannabidiol (CBD) products are proliferating around the country.”

“We worked hard to craft a bill that would provide the agency with tailored authorities to address the concerns FDA has raised in order to establish a workable, responsible framework for the regulation of hemp-derived CBD in conventional food products,” wrote bill sponsors.


Primary Sponsor

Karma Koala Podcast

Top Marijuana Blog